Substance active (DCI)
- crisantaspase recombinante
Informations techniques
Exploitant
JAZZ PHARMACEUTICALS
Présentation
ENRYLAZE 10 mg/0,5 mL, solution injectable / pour perfusion
3 flacons en verre de 0,5 ml (CIP : 34009 550 986 8 3)
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
GXWqRUsVUbadAb8b
Écouter
Français